-
Duloxetine for the Treatment of Major Depressive Disorder
By Charles B. Nemeroff, MD, PhD, Alan F. Schatzberg, MD, David J. Goldstein, MD, PhD, Michael J. Detke, MD, PhD, Craig Mallinckrodt, PhD, Yili Lu, PhD, and Pierre V. Tran, MD
-
The Effect of Food on the Absorption of Oral Ziprasidone
By Jeffrey J.Miceli, PhD, Paul Glue, MD, PhD, Jeffrey Alderman, PhD, and Keith Wilner, PhD
-
Ethical Issues In Schizophrenia: Considerations for Treatment and ResearchBy Laura B. Dunn, MD
-
Neuropsychiatric Update: Neuroimaging Schizophrenia
By Shawn J. Kile, MD
-
Genetics of Schizophrenia: Recent Advances
By Amy Eisener, BS, Michele T. Pato, MD, Helena Medeiros, MSW, Celia Carvalho, MS, and Carlos N. Pato, MD
-
Gender and Schizophrenia
By Carla M. Canuso, MD and Gahan Pandina, PhD
-
Efficacy of Combined Pharmacological and Cognitive- Behavioral Treatments For Anxiety Disorders
By Steven E. Bruce, PhD and Kamila S. White, PhD
-
Psychiatric Bulletin:
Late-Breaking Clinical News
-
The MentalFitness Interview: David Shaffer, FRCP, FRCPsych, on the Rise and Fall of the Teen Suicide Rate -
Cause & Effect
Dealing with the Loss of a Spouse
By Dina Kerasiotis, RN, PsyD
-
Anxiety Disorders
Overview:
Vast Progress but a Long Journey Ahead
By Tracey M. Boudine
-
Economic Impacts of Anxiety Disorders
By Ernst R. Berndt, PhD and Tamar Sisitsky, MA
-
Panic Disorder During Pregnancy
By Dana March, BA and Kimberly A. Yonkers, MD
-
Recognition and Treatment of Anxiety Disorders in Primary Care
By Risa B. Weisberg, PhD and Kristin M. Maki, PhD
